These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35564855)

  • 1. Factors Associated with Colorectal Cancer Screening in Spain: Results of the 2017 National Health Survey.
    Nouni-García R; Lara-López Á; Carratalá-Munuera C; Gil-Guillén VF; López-Pineda A; Orozco-Beltrán D; Quesada JA
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of colorectal cancer test use, including CT colonography, in the 2010 National Health Interview Survey.
    Shapiro JA; Klabunde CN; Thompson TD; Nadel MR; Seeff LC; White A
    Cancer Epidemiol Biomarkers Prev; 2012 Jun; 21(6):895-904. PubMed ID: 22490320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adherence to and predictors of participation in colorectal cancer screening with faecal occult blood testing in Spain, 2009-2011.
    Ricardo-Rodrigues I; Jiménez-García R; Hernández-Barrera V; Carrasco-Garrido P; Jiménez-Trujillo I; López-de-Andrés A
    Eur J Cancer Prev; 2015 Jul; 24(4):305-12. PubMed ID: 25304027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician-office vs home uptake of colorectal cancer screening using FOBT/FIT among screening-eligible US adults.
    Chido-Amajuoyi OG; Sharma A; Talluri R; Tami-Maury I; Shete S
    Cancer Med; 2019 Dec; 8(17):7408-7418. PubMed ID: 31637870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of National Colorectal Cancer Screening Program in Croatia (2007-2011).
    Katičić M; Antoljak N; Kujundžić M; Stamenić V; Skoko Poljak D; Kramarić D; Stimac D; Strnad Pešikan M; Samija M; Ebling Z
    World J Gastroenterol; 2012 Aug; 18(32):4300-7. PubMed ID: 22969192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
    Todorov K; Wilson C; Sharplin G; Corsini N
    Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a population-based colorectal cancer screening program on local health services demand in Italy: a 7-year survey in a northern province.
    Parente F; Marino B; Ardizzoia A; Ucci G; Ilardo A; Limonta F; Villani P; Moretti R; Zucchi A; Cremaschini M; Pirola ME
    Am J Gastroenterol; 2011 Nov; 106(11):1986-93. PubMed ID: 21670773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fecal occult blood testing: people in Ontario are unaware of it and not ready for it.
    Ritvo P; Myers R; Del Giudice ME; Pazsat L; Cotterchio M; Howlett R; Mai V; Brown P; Sullivan T; Rabeneck L
    Can Fam Physician; 2009 Feb; 55(2):176-177.e4. PubMed ID: 19221081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The populations attitudes to colorectal cancer screening in the Czech Republic].
    Král N; Seifert B; Suchánek Š; Zavoral M; Májek O
    Epidemiol Mikrobiol Imunol; 2015 Mar; 64(1):41-6. PubMed ID: 25872995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Faecal occult blood test and colonoscopy use in Portugal: Results from the National Health Survey 2014.
    Khan H; Shaaban N; Peleteiro B
    J Med Screen; 2020 Dec; 27(4):171-185. PubMed ID: 31865864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Community-based preferences for stool cards versus colonoscopy in colorectal cancer screening.
    DeBourcy AC; Lichtenberger S; Felton S; Butterfield KT; Ahnen DJ; Denberg TD
    J Gen Intern Med; 2008 Feb; 23(2):169-74. PubMed ID: 18157581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilization of lower gastrointestinal endoscopy and fecal occult blood test in 11 European countries: evidence from the Survey of Health, Aging and Retirement in Europe (SHARE).
    Stock C; Brenner H
    Endoscopy; 2010 Jul; 42(7):546-56. PubMed ID: 20432204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors of Never Screened with Faecal Occult Blood Test in Public Primary Care Facilities.
    Sazali MF; Syed Abdul Rahim SS; Avoi R; Hassan MR; Hayati F; Azhar ZI; Jeffree MS; Awang Lukman K; Oo Tha N; Sajali H; Atil A; Abd Rahim MA
    Asian Pac J Cancer Prev; 2021 Jan; 22(1):163-169. PubMed ID: 33507695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunochemical testing of individuals positive for guaiac faecal occult blood test in a screening programme for colorectal cancer: an observational study.
    Fraser CG; Matthew CM; Mowat NA; Wilson JA; Carey FA; Steele RJ
    Lancet Oncol; 2006 Feb; 7(2):127-31. PubMed ID: 16455476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
    Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
    J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing colonoscopy behaviour among Koreans with a positive faecal occult blood tests.
    Choi E; Jeon J; Kim J
    Eur J Cancer Care (Engl); 2019 Mar; 28(2):e13008. PubMed ID: 30748048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review in depth and meta-analysis of controlled trials on colorectal cancer screening by faecal occult blood test.
    Heresbach D; Manfredi S; D'halluin PN; Bretagne JF; Branger B
    Eur J Gastroenterol Hepatol; 2006 Apr; 18(4):427-33. PubMed ID: 16538116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population characteristics related to colorectal cancer testing in New South Wales, Australia: results from the 45 and Up Study cohort.
    Weber MF; Banks E; Ward R; Sitas F
    J Med Screen; 2008; 15(3):137-42. PubMed ID: 18927096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in colonoscopy and fecal occult blood test use after the introduction of dual screening offers in Germany: Results from a large population-based study, 2003-2016.
    Chen C; Stock C; Jansen L; Chang-Claude J; Hoffmeister M; Brenner H
    Prev Med; 2019 Jun; 123():333-340. PubMed ID: 30946858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening.
    Dekker N; van Rossum LG; Van Vugt-van Pinxteren M; van Stiphout SH; Hermens RP; van Zelst-Stams WA; van Oijen MG; Laheij RJ; Jansen JB; Hoogerbrugge N
    Eur J Cancer; 2011 Jul; 47(10):1571-7. PubMed ID: 21367600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.